{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:23:10Z","timestamp":1790392990980,"version":"4.1.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81303077"],"award-info":[{"award-number":["81303077"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Project of Medicine Science and Technology Development of Shandong","award":["2017WS268"],"award-info":[{"award-number":["2017WS268"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2018LH012"],"award-info":[{"award-number":["ZR2018LH012"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Program Project of Shandong Academy of Medical Sciences","award":["2018-15"],"award-info":[{"award-number":["2018-15"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.intimp.2019.04.057","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T05:24:57Z","timestamp":1557379497000},"page":"10-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Natural killer cells involved in tumour immune escape of hepatocellular carcinomar"],"prefix":"10.1016","volume":"73","author":[{"given":"Chen","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2035-3527","authenticated-orcid":false,"given":"Hengxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.04.057_bb0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3449","article-title":"Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma","volume":"13","author":"Arzumanyan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2019.04.057_bb0010","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2217\/hep-2017-0019","article-title":"Biomarker development for hepatocellular carcinoma early detection: current and future perspectives","volume":"4","author":"Sengupta","year":"2017","journal-title":"Hepatic oncology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/bjs5.9","article-title":"Association between hospital volume and in-hospital mortality following radiofrequency ablation for hepatocellular carcinoma","volume":"1","author":"Sato","year":"2017","journal-title":"BJS Open"},{"key":"10.1016\/j.intimp.2019.04.057_bb0025","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.4254\/wjh.v7.i12.1632","article-title":"Guide for diagnosis and treatment of hepatocellular carcinoma","volume":"7","author":"Attwa","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00109-015-1376-x","article-title":"Immunosuppressive cells in tumor immune escape and metastasis","volume":"94","author":"Liu","year":"2016","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.intimp.2019.04.057_bb0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.hemonc.2014.11.006","article-title":"Natural killer cells: in health and disease","volume":"8","author":"Mandal","year":"2015","journal-title":"Hematology\/Oncology and Stem Cell Therapy"},{"key":"10.1016\/j.intimp.2019.04.057_bb0040","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3389\/fimmu.2018.01869","article-title":"Natural killer cells: development, maturation, and clinical utilization","volume":"9","author":"Abel","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc.2015.5","article-title":"NK cells and cancer: you can teach innate cells new tricks","volume":"16","author":"Morvan","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2019.04.057_bb0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.coi.2004.11.001","article-title":"NK cells in innate immunity","volume":"17","author":"Hamerman","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0055","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/cmi.2017.72","article-title":"Liver-resident NK cells and their potential functions","volume":"14","author":"Peng","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ni.1962","article-title":"The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling","volume":"12","author":"Spits","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0065","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fimmu.2017.00360","article-title":"Modeling human natural killer cell development in the era of innate lymphoid cells","volume":"8","author":"Scoville","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0070","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3389\/fimmu.2015.00605","article-title":"Natural killer cell-based therapies targeting Cancer: possible strategies to gain and sustain anti-tumor activity","volume":"6","author":"Dahlberg","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-981-10-5987-2_11","article-title":"The development and diversity of ILCs, NK cells and their relevance in health and diseases","volume":"1024","author":"Zhang","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0080","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0085","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2005.10.001","article-title":"Human natural killer cell development and biology","volume":"20","author":"Farag","year":"2006","journal-title":"Blood Rev."},{"key":"10.1016\/j.intimp.2019.04.057_bb0095","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3389\/fimmu.2017.00699","article-title":"Human CD56(dim)CD16(dim) cells as an individualized natural killer cell subset","volume":"8","author":"Amand","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.22034","article-title":"Liver: an organ with predominant innate immunity","volume":"47","author":"Gao","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1034\/j.1600-0528.2002.017416.x","article-title":"Innate and adaptive lymphoid cells in the human liver","volume":"174","author":"Doherty","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2019.04.057_bb0110","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/hep.26115","article-title":"Natural killer cells in liver disease","volume":"57","author":"Tian","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1615\/CritRevImmunol.v31.i1.40","article-title":"Regulation of NK cell repertoire and function in the liver","volume":"31","author":"Krueger","year":"2011","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0120","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nri3065","article-title":"Organ-specific features of natural killer cells","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.it.2015.03.006","article-title":"Re-examining the origin and function of liver-resident NK cells","volume":"36","author":"Peng","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0130","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.21035","article-title":"Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans","volume":"43","author":"Ishiyama","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0135","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6903496","article-title":"NK cell subtypes as regulators of autoimmune liver disease","volume":"2016","author":"Jiao","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.intimp.2019.04.057_bb0140","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1189\/jlb.72.4.668","article-title":"Hepatic natural killer cells exclusively kill splenic\/blood natural killer-resistant tumor cells by the perforin\/granzyme pathway","volume":"72","author":"Vermijlen","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1615\/CritRevOncog.2014010805","article-title":"Positive and negative regulation by NK cells in cancer","volume":"19","author":"Sungur","year":"2014","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.intimp.2019.04.057_bb0150","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/icb.2010.78","article-title":"Activating and inhibitory receptors of natural killer cells","volume":"89","author":"Pegram","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0155","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3389\/fimmu.2015.00601","article-title":"Natural killer cell immunomodulation: targeting activating, inhibitory, and co-stimulatory receptor signaling for Cancer immunotherapy","volume":"6","author":"Chester","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0160","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1309\/AJCPWGG69MCZOWMM","article-title":"Expression of the activating receptor, NKp46 (CD335), in human natural killer and T-cell neoplasia","volume":"140","author":"Freud","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0165","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-4614-9437-9_9","article-title":"Natural killer cells and killer-cell immunoglobulin-like receptor polymorphisms: their role in hematopoietic stem cell transplantation","volume":"1109","author":"Schellekens","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0170","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1016\/j.jmb.2016.09.011","article-title":"Structural insights into the inhibitory mechanism of an antibody against B7-H6, a stress-induced cellular ligand for the natural killer cell receptor NKp30","volume":"428","author":"Xu","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0175","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1615\/CritRevImmunol.2014012220","article-title":"Inhibitory receptor-mediated regulation of natural killer cells","volume":"34","author":"Alari-Pahissa","year":"2014","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0180","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/cmi.2014.91","article-title":"NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma","volume":"12","author":"Sun","year":"2015","journal-title":"Cellular & Molecular Immunology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0185","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/eji.201344272","article-title":"Effect of tumor cells and tumor microenvironment on NK-cell function","volume":"44","author":"Vitale","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0190","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4161\/auto.26924","article-title":"Autophagic degradation of GZMB\/granzyme B: a new mechanism of hypoxic tumor cell escape from natural killer cell-mediated lysis","volume":"10","author":"Viry","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.intimp.2019.04.057_bb0195","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000327014","article-title":"Mechanisms of tumor and viral immune escape from natural killer cell-mediated surveillance","volume":"3","author":"Groth","year":"2011","journal-title":"Journal of Innate Immunity"},{"key":"10.1016\/j.intimp.2019.04.057_bb0200","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fimmu.2017.00760","article-title":"NK Cell Exhaustion","volume":"8","author":"Bi","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0205","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.clim.2008.08.012","article-title":"Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients","volume":"129","author":"Cai","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0210","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1048061","article-title":"Failure recovery of circulating NKG2D(+)CD56(dim)NK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence","volume":"5","author":"Gao","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0215","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1154249","article-title":"Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments","volume":"5","author":"Cariani","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0220","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2567.2011.03446.x","article-title":"CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells","volume":"133","author":"Fu","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0225","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/cmi.2016.28","article-title":"Liver-infiltrating CD11b(\u2212)CD27(\u2212) NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression","volume":"14","author":"Zhang","year":"2017","journal-title":"Cellular & Molecular Immunology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","article-title":"Natural innate and adaptive immunity to cancer","volume":"29","author":"Vesely","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0235","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/ni0508-477","article-title":"Natural killer cell recognition of missing self","volume":"9","author":"Karre","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0240","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2018.00476","article-title":"NKG2D and its ligands: \"one for all, all for one\"","volume":"9","author":"Zingoni","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081677","article-title":"Regulation of NKG2D-dependent NK cell functions: the Yin and the Yang of receptor endocytosis","volume":"18","author":"Molfetta","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2019.04.057_bb0250","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nri2144","article-title":"Promiscuity and the single receptor: NKG2D","volume":"7","author":"Eagle","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0255","doi-asserted-by":"crossref","first-page":"ra108","DOI":"10.1126\/scisignal.aab2724","article-title":"Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells","volume":"8","author":"Quatrini","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.intimp.2019.04.057_bb0260","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4049\/jimmunol.168.2.671","article-title":"UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells","volume":"168","author":"Sutherland","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0265","doi-asserted-by":"crossref","DOI":"10.4161\/onci.26097","article-title":"New prospects on the NKG2D\/NKG2DL system for oncology","volume":"2","author":"Ullrich","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0270","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"Raulet","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0275","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/2326-6066.CIR-15-0098","article-title":"NKG2D receptor and its ligands in host defense","volume":"3","author":"Lanier","year":"2015","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/j.intimp.2019.04.057_bb0280","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.imlet.2017.04.006","article-title":"NKG2D: a versatile player in the immune system","volume":"189","author":"Jelencic","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2019.04.057_bb0285","doi-asserted-by":"crossref","unstructured":"Mistry AR, O'Callaghan CA. Regulation of ligands for the activating receptor NKG2D. Immunology. 2007;121:439\u201347.","DOI":"10.1111\/j.1365-2567.2007.02652.x"},{"key":"10.1016\/j.intimp.2019.04.057_bb0290","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nature03884","article-title":"The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor","volume":"436","author":"Gasser","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2019.04.057_bb0295","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.4049\/jimmunol.181.10.6711","article-title":"Interaction of monocytes with NK cells upon toll-like receptor-induced expression of the NKG2D ligand MICA","volume":"181","author":"Kloss","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0300","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/ijc.10966","article-title":"Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid","volume":"104","author":"Jinushi","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2019.04.057_bb0305","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13046-014-0076-7","article-title":"MICA\/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma","volume":"33","author":"Fang","year":"2014","journal-title":"Journal of Experimental & Clinical Cancer Research: CR"},{"key":"10.1016\/j.intimp.2019.04.057_bb0310","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jhep.2009.12.030","article-title":"Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma","volume":"52","author":"Kohga","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0315","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/hep.23456","article-title":"Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain a on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9","volume":"51","author":"Kohga","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0320","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.intimp.2016.03.045","article-title":"Scorpion venom activates natural killer cells in hepatocellular carcinoma via the NKG2D-MICA pathway","volume":"35","author":"Chen","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0325","doi-asserted-by":"crossref","first-page":"12049","DOI":"10.1074\/jbc.M110.159756","article-title":"Overexpression of IL-32alpha increases natural killer cell-mediated killing through up-regulation of Fas and UL16-binding protein 2 (ULBP2) expression in human chronic myeloid leukemia cells","volume":"286","author":"Cheon","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2019.04.057_bb0330","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1038\/srep06138","article-title":"The regulatory effect of UL-16 binding protein-3 expression on the cytotoxicity of NK cells in cancer patients","volume":"4","author":"Mou","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2019.04.057_bb0335","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jhep.2011.06.017","article-title":"Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence","volume":"56","author":"Kamimura","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0340","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1264562","article-title":"High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer","volume":"6","author":"Sun","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0345","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0350","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.4049\/jimmunol.0901362","article-title":"Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state","volume":"184","author":"Lassen","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0355","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2019.04.057_bb0360","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4049\/jimmunol.162.1.305","article-title":"Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94\/NKG2A and NK cells","volume":"162","author":"Brooks","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0365","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1158\/2326-6066.CIR-14-0096","article-title":"Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity","volume":"2","author":"Cheung","year":"2014","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/j.intimp.2019.04.057_bb0370","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/imm.12516","article-title":"Critical roles of co-activation receptor DNAX accessory molecule-1 in natural killer cell immunity","volume":"146","author":"Xiong","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0375","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/his.12584","article-title":"Loss of CD155 expression predicts poor prognosis in hepatocellular carcinoma","volume":"66","author":"Qu","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0380","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1002\/eji.201444574","article-title":"UPR decreases CD226 ligand CD155 expression and sensitivity to NK cell-mediated cytotoxicity in hepatoma cells","volume":"44","author":"Gong","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0385","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nrc1505","article-title":"The role of the unfolded protein response in tumour development: friend or foe?","volume":"4","author":"Ma","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2019.04.057_bb0390","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","article-title":"Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma","volume":"144","author":"Hernandez-Gea","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0395","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0400","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2019.04.057_bb0405","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1189\/jlb.0609385","article-title":"Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation","volume":"86","author":"Solinas","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cmi.2014.83","article-title":"The origin and function of tumor-associated macrophages","volume":"12","author":"Liu","year":"2015","journal-title":"Cellular & Molecular Immunology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0415","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/156652413804486269","article-title":"The influence of macrophages and the tumor microenvironment on natural killer cells","volume":"13","author":"Krneta","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.intimp.2019.04.057_bb0420","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/hep.26192","article-title":"Monocyte\/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48\/2B4 interactions","volume":"57","author":"Wu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0425","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00281-016-0597-6","article-title":"Myeloid-derived suppressor cells and tumor escape from immune surveillance","volume":"39","author":"Umansky","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0430","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10555-011-9280-5","article-title":"Improving cancer immunotherapy by targeting tumor-induced immune suppression","volume":"30","author":"Stewart","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.intimp.2019.04.057_bb0435","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.semcancer.2005.07.005","article-title":"Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression","volume":"16","author":"Serafini","year":"2006","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0440","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2008.03.020","article-title":"A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells","volume":"135","author":"Hoechst","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0445","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/hep.23054","article-title":"Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor","volume":"50","author":"Hoechst","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0450","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2019.04.057_bb0455","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.24485","article-title":"Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts","volume":"54","author":"Mazzocca","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0460","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2019.04.057_bb0465","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/BST20160387","article-title":"Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis","volume":"45","author":"Erdogan","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.intimp.2019.04.057_bb0470","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.celrep.2016.04.019","article-title":"Cancer-associated fibroblasts regulate tumor-initiating cell plasticity in hepatocellular carcinoma through c-met\/FRA1\/HEY1 signaling","volume":"15","author":"Lau","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2019.04.057_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020405","article-title":"Tumor microenvironment, a paradigm in hepatocellular carcinoma progression and therapy","volume":"18","author":"Tahmasebi Birgani","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2019.04.057_bb0480","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.3748\/wjg.v22.i30.6841","article-title":"Cancer-associated fibroblasts in hepatocellular carcinoma","volume":"22","author":"Kubo","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0485","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.smim.2017.09.001","article-title":"Tailoring natural killer cell immunotherapy to the tumour microenvironment","volume":"31","author":"Barrow","year":"2017","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0490","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canlet.2011.12.020","article-title":"Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO","volume":"318","author":"Li","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2019.04.057_bb0495","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/03009734.2011.638729","article-title":"Tumor-promoting functions of transforming growth factor-beta in progression of cancer","volume":"117","author":"Miyazono","year":"2012","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.intimp.2019.04.057_bb0500","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000327560","article-title":"Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-beta signaling in hepatocarcinogenesis","volume":"29","author":"Yamazaki","year":"2011","journal-title":"Dig. Dis."},{"key":"10.1016\/j.intimp.2019.04.057_bb0505","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.4049\/jimmunol.1302389","article-title":"NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma","volume":"193","author":"Sui","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0510","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6374379","article-title":"NK-DC crosstalk in immunity to microbial infection","volume":"2016","author":"Thomas","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.intimp.2019.04.057_bb0515","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.it.2003.10.012","article-title":"NK cell and DC interactions","volume":"25","author":"Cooper","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0520","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2249.2011.04421.x","article-title":"Alpha-fetoprotein impairs activation of natural killer cells by inhibiting the function of dendritic cells","volume":"165","author":"Yamamoto","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2019.04.057_bb0525","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.canlet.2015.09.017","article-title":"TLR7\/8 agonists promote NK-DC cross-talk to enhance NK cell anti-tumor effects in hepatocellular carcinoma","volume":"369","author":"Zhou","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2019.04.057_bb0530","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/cmi.2011.23","article-title":"Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy","volume":"9","author":"Nguyen-Pham","year":"2012","journal-title":"Cellular & Molecular Immunology"},{"key":"10.1016\/j.intimp.2019.04.057_bb0535","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/1097-0215(20000901)87:5<665::AID-IJC8>3.0.CO;2-F","article-title":"Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses","volume":"87","author":"Furumoto","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2019.04.057_bb0540","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1517\/14712598.5.10.1303","article-title":"Natural killer-dendritic cell cross-talk in cancer immunotherapy","volume":"5","author":"Kalinski","year":"2005","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.intimp.2019.04.057_bb0545","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2005.05.026","article-title":"Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain a in advanced human hepatocellular carcinomas","volume":"43","author":"Jinushi","year":"2005","journal-title":"J. Hepatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918312487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918312487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:13:12Z","timestamp":1761585192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918312487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":109,"alternative-id":["S1567576918312487"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.04.057","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural killer cells involved in tumour immune escape of hepatocellular carcinomar","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.04.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}